Category: FSP

When it Comes to Diversity in Clinical Trials, Big Data is a Big Deal

Overcoming Barriers to Large Global Studies: Cardiovascular Outcomes and Vaccine Trial Leaders on Research Methods That Made a Difference

Moderna Completes Enrollment of Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273)

Why PPD’s Global Clinical Supply Functional Service is the Right Choice to Navigate Your Trials Through Brexit

Strategically Selecting the Right Outsourcing Model for Drug Development — Considerations for Emerging Biotech

Using Technology to Overcome Resourcing Challenges

Moderna Announces Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273) Begins

Regulatory Affairs: Mitigating COVID-19’s Impact on Clinical Trials

Successful Partnering in Pharmacovigilance For Clinical Trials